snk01
nkgen,spdr s&p biotech,ishares biotechnology
['snk-01', 'nkgen', '$ibb', '$xbi']
nkgen biotech presents promising preclinical &amp; phase i/iia clinical data for snk-01 at the 2023 asco annual meeting more info: $xbi $ibb $xph $pph 
BioPharma/Biotech Intel.  Daily $XBI $XPH Market Movers

Database: https://t.co/IBOqbSoYuc
Clinical trial tools: https://t.co/A77u9Q84Dc  http://globalclinicalt